Coronavirus Daily Update: COVID-19 cases explained in charts

India has reported 44,489 new cases of coronavirus on November 26, the 19th day in a row that than new infections remained below 50,000 but active cases are rising again.

Chaitanya Mallapur

November 26, 2020 / 10:53 AM IST

India reported 44,489 new cases of the novel coronavirus in the last 24 hours, pushing the country's COVID-19 tally above 92 lakh, the health ministry’s said on November 26.

The country also reported 524 new deaths and 36,367 recoveries, the latest ministry release shows. Active cases increased to 4,52,344 with a rise of 7,598 cases in a day, the highest rise after September 18.

Kerala reported the most (6,491) new cases followed by Maharashtra (6,159), Delhi (5,246), West Bengal (3,528) and Rajasthan (3,285). These five states account for more than half (56 percent) of all the new cases in India.

covid-19-update_Nov 26

Rajasthan reported more than 3,000 cases for the fifth consecutive day. The state has the fourth-highest active cases in India.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show